2014
DOI: 10.1016/j.resuscitation.2013.10.022
|View full text |Cite
|
Sign up to set email alerts
|

Delta opioid receptor agonist BW373U86 attenuates post-resuscitation brain injury in a rat model of asphyxial cardiac arrest

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
8
1

Year Published

2015
2015
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 11 publications
(9 citation statements)
references
References 32 publications
0
8
1
Order By: Relevance
“…We detected both MOR and DOR proteins in microglia derived from the hypothalamus using both immunocytochemistry and flow cytometry methods. The difference between our and Mika et al [33] findings might be related to differential characteristics of microglia in various parts of the brain [34]. …”
Section: Discussioncontrasting
confidence: 98%
“…We detected both MOR and DOR proteins in microglia derived from the hypothalamus using both immunocytochemistry and flow cytometry methods. The difference between our and Mika et al [33] findings might be related to differential characteristics of microglia in various parts of the brain [34]. …”
Section: Discussioncontrasting
confidence: 98%
“…An intriguing possibility is that arrest in the context of antecedent use of opioids or benzodiazepines may actually protect the brain from anoxic injury, either by decreasing the cerebral metabolic oxygen demand or through direct neuroprotective mechanisms. Animal models of cardiac arrest or anoxic brain injury have supported the concept of neuroprotection by benzodiazepines [ 22 ] and opioid agonists [ 23 , 24 ]. In humans, observational data have associated opioid use immediately before or during CPR with improved survival from in-hospital cardiac arrest [ 25 ].…”
Section: Discussionmentioning
confidence: 99%
“…Traditional concern has been for elevation in intracranial pressure, however use of the NMDA antagonist ketamine has been associated with similar ICP effects as opioids when used for sedation in patients with intracranial pathology [ 22 ]. Finally, opioid agonists, while contributing to sedation and potentially diminished cerebral oxygen demand, may also contribute to cerebral cellular preservation via δ-opioid receptor associated reduction in the kinases ERK1 and ERK2 and TNF-α inflammatory mediator activity and production [ 23 ]. Opioid agonist effects at receptors other than the well-studied μ-receptor may have neuroprotective applications as further evidence is elucidated.…”
Section: Discussionmentioning
confidence: 99%
“…Even after return of spontaneous circulation, reperfusion injury, cerebral edema and inflammation could exist for long time and lead to massive apoptosis of neuronal cells 17, 23 . It is well known that neuronal cell apoptosis is one of the main pathological change induced by CA post-ROSC, which is also the main form of brain cell death.…”
Section: Discussionmentioning
confidence: 99%